OpenVSafe by OpenVAERS
Search V-safe

FVP-21489-14947

2 vaccinations 5 coded responses 15 check-ins 5 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
784 / TX
Registered
2021-03-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
QV3-21841-24143 Child or adolescent in my care · Male · 2021-08-27
JRE-12543-36253 Child or adolescent in my care · Male · 2021-11-07
5HE-17093-61557 Child or adolescent in my care · Female · 2021-11-07
SDF-82041-15525 Child or adolescent in my care · Male · 2021-11-07

Timeline

  1. 2021-02-23
    Dose 1 — Moderna
  2. 2021-03-19
    Registered in v-safe
  3. 2021-03-19
    Survey response — day 21, dose 1
    MedDRA: Lymphadenopathy, Musculoskeletal stiffness — Feeling: Good
    Free text: Stiffness on both sides of my neck, swollen glands/lymph nodes along throat and breast/underarms.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-23
    Dose 2 — Moderna
  5. 2021-03-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Flatulence — Feeling: Good · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain
    Free text: Intestinal gas overnight
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness · None
    Adult check-in
  7. 2021-03-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-03-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-03-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-03-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-03-30
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-04-06
    Survey response — day 14, dose 2
    MedDRA: Headache, Pyrexia — Feeling: Good
    Free text: Headache and low-grade fever on 4/3/2021.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-13
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-04-22
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-04-27
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-05-04
    Survey response — day 42, dose 2
    MedDRA: Anxiety, Eye disorder, Headache, Pre-existing disease — Feeling: Good
    Free text: Eyes over- and under-dilated. Increase in anxiety attacks. Pain in the top of my head/brain, off and on over the past six weeks. Unsure of any relation to the vaccine, but listing what other health issues I have encountered recently.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-06-22
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-09-21
    Survey response — 6 months, dose 2
    MedDRA: Diplopia, Miosis, Office visit, Vision blurred — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Tonic pupil in my left eye. Double or blurred vision. · Healthcare visit (other): Primary care physician, ophthalmologist, neurologist, and neurologist specialist
    MedDRA releases: 2024-11 · check-in free text available
  19. 2021-09-21
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-09-23
  21. 2021-12-07
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-02-23Moderna
22021-03-23Moderna

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 5 — day 21, dose 1

2021-03-19

Symptoms: Stiffness on both sides of my neck, swollen glands/lymph nodes along throat and breast/underarms.

Release 6 — days 1–6 daily, dose 2

2021-03-24

Systemic reaction (other): Intestinal gas overnight

Release 7 — day 14, dose 2

2021-04-06

Symptoms: Headache and low-grade fever on 4/3/2021.

Release 8 — day 42, dose 2

2021-05-04

Symptoms: Eyes over- and under-dilated. Increase in anxiety attacks. Pain in the top of my head/brain, off and on over the past six weeks. Unsure of any relation to the vaccine, but listing what other health issues I have encountered recently.

Release 9 — 6 months, dose 2

2021-09-21

Symptoms: Tonic pupil in my left eye. Double or blurred vision.
Healthcare visit (other): Primary care physician, ophthalmologist, neurologist, and neurologist specialist

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDAnxiety ✓ ✓ ✓
SDDiplopia · · ✓
SDEye disorder ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDLymphadenopathy ✓ ✓ ✓
SDMiosis · · ✓
SDMusculoskeletal stiffness ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDPyrexia ✓ ✓ ✓
SDVision blurred · · ✓
SROFlatulence ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release